OPPENHEIMER & CO INC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$1,391
-31.5%
12,0000.0%0.00%
Q4 2022$2,032
+1.6%
12,0000.0%0.00%
Q3 2022$2,000
-66.7%
12,0000.0%0.00%
Q2 2022$6,000
-14.3%
12,0000.0%0.00%
Q1 2022$7,0000.0%12,0000.0%0.00%
Q4 2021$7,000
-41.7%
12,0000.0%0.00%
Q3 2021$12,000
-7.7%
12,0000.0%0.00%
Q2 2021$13,000
+18.2%
12,0000.0%0.00%
Q1 2021$11,000
+83.3%
12,0000.0%0.00%
Q4 2020$6,000
-33.3%
12,0000.0%0.00%
Q3 2020$9,0000.0%12,000
-25.0%
0.00%
Q2 2020$9,000
+50.0%
16,0000.0%0.00%
Q1 2020$6,000
-45.5%
16,0000.0%0.00%
Q4 2019$11,0000.0%16,0000.0%0.00%
Q3 2019$11,000
-47.6%
16,0000.0%0.00%
-100.0%
Q2 2019$21,000
-41.7%
16,000
-5.9%
0.00%0.0%
Q1 2019$36,000
-5.3%
17,0000.0%0.00%0.0%
Q4 2018$38,00017,0000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Sterling Global Strategies LLC 21,940$71,0000.46%
Leisure Capital Management 157,301$503,0000.43%
BARD ASSOCIATES INC 759,000$2,430,0000.23%
Stonebridge Capital Advisors LLC 32,500$104,0000.02%
LEVEL FOUR ADVISORY SERVICES, LLC 63,500$203,0000.02%
DekaBank Deutsche Girozentrale 700,000$2,240,0000.02%
B. Riley Wealth Advisors, Inc. 21,350$69,0000.01%
Jacobi Capital Management LLC 7,421$24,0000.01%
Versant Capital Management, Inc 4,092$13,0000.01%
Cable Hill Partners, LLC 4,000$13,0000.01%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders